Effects of angiogenic growth factor combinations on retinal endothelial cells

Experimental Eye Research

Volumn 74, Issue 4, 2002, Pages 523-535

  Castellon, Raquel ^a   Hamdi, Hamdi K ^a   Sacerio, Ingrid ^a   Aoki, Annette M ^a   Cristina Kenney, M ^a   Ljubimov, Alexander V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Diabetic retinopathy; FGF 2; Growth factor; IGF I; Invasion; Matrigel; Migration; PDGF; PlGF; Proliferation; Retinal endothelial cell; Sprouting; Synergy; Tube formation; VEGF

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN C; UNCLASSIFIED DRUG; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL TISSUE; BASEMENT MEMBRANE; CAPILLARY; CELL AGGREGATION; CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; RETINA CELL;

EID: 0036310966     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.2001.1161     Document Type: Article

References (66)

1. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
2. Vascular endothelial growth factor and the eye: Biochemical mechanisms of action and implications for novel therapies
3. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies
4. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
5. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform-selective inhibitor
6. Diabetic eye disease
7. Diabetic retinopathy
8. Molecular mechanisms of growth factor action in diabetic retinopathy
9. Role of vascular endothelial growth factor in diabetic vascular complications
10. Endothelial differentiation using Matrigel
11. In vitro models of angiogenesis: The use of Matrigel
12. Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor
13. Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management
14. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: A case-control study
15. Regulation of adipocyte precursor DNA synthesis by acidic and basic fibroblast growth factors: Interaction with heparin and other growth factors
16. Retinal and choroidal neovascularization
17. Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy
18. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR
19. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor
20. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
21. Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor heterodimer
22. Kinetics of placenta growth factor/vascular endothelial growth factor synergy in endothelial hydraulic conductivity and proliferation
23. Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth
24. Vascular endothelial growth factor and retinal neovascularisation: A new therapeutic approach for diabetic retinopathy
25. Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy
26. Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation
27. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
28. Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin
29. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization
30. Hepatocyte growth factor/scatter factor in the eye
31. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogenactivated protein kinase-dependent pathway
32. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity
33. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR)
34. Growth-factor-dependent mitogenesis requires two distinct phases of signaling
35. Increased expression of placenta growth factor in proliferative diabetic retinopathy
36. Basement membrane complexes with biological activity
37. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma
38. Migratory and proliferative effect of platelet-derived growth factor in rabbit retinal endothelial cells: Evidence of an autocrine pathway of platelet-derived growth factor
39. Regulation of distinct steps of angiogenesis by different angiogenic molecules
40. Automated evaluation of angiogenic effects mediated by VEGF and PlGF homo- and heterodimers
41. Angiogenesis: Regulators and clinical applications
42. Distribution of individual components of basement membrane in human colon polyps and adenocarcinomas as revealed by monoclonal antibodies
43. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like reactivity in proliferative diabetic retinopathy
44. Current hypotheses for the biochemical basis of diabetic retinopathy
45. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels
46. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization
47. Growth factors and diabetic retinopathy
48. VEGF signal transduction proteins ERK-1 and ERK-2 are targets for the inhibition of retinal angiogenesis
49. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
50. Growth factor alterations in advanced diabetic retinopathy: A possible role of blood retina barrier breakdown
51. Inhibition of cell migration by 24-kDa fibroblast growth factor-2 is dependent upon the estrogen receptor
52. Endothelial cell apoptosis in capillary network remodeling
53. Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF 2-transfected endothelial and tumour cells
54. Characterization of the growth of murine tibroblasts that express human insulin receptors. II. Interaction of insulin with other growth factors
55. IGF-I increases bFGF-induced mitogenesis and upregulates FGFR-1 in rabbit vascular smooth muscle cells
56. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases
57. Collagen gel assay for angiogenesis
58. Neovascular growth factors
59. Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway
60. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
61. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
62. Basement membrane and growth factor gene expression in normal and diabetic human retinas
63. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
64. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components
65. Nerve growth factor increases the mitogenicity of certain growth factors for cultured human keratinocytes: A comparison with epidermal growth factor
66. Placenta growth factor-1 is chemotactic, mitogenic and angiogenic